Evidence map›Paper›PMID 37947817›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2024

The impact of tamoxifen treatment on voice parameters in premenopausal women with breast cancer.

Serdar Ata, Nur Yücel Ekici, Mahmut Büyükşimşek, Timuçin Çil, Berna Bozkurt Duman

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 75% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Serdar AtaDepartment of Medical Oncology, Adana City Training and Research Hospital, University of Health Sciences, Adana, Turkey. drserdarata@gmail.com.ORCID http://orcid.org/0000-0002-8269-9884
Nur Yücel EkiciDepartment of Otorhinolaryngology, Adana City Training and Research Hospital, University of Health Sciences, Adana, Turkey.
Mahmut BüyükşimşekDepartment of Medical Oncology, Adana City Training and Research Hospital, University of Health Sciences, Adana, Turkey.ORCID http://orcid.org/0000-0001-6356-9059
Timuçin ÇilDepartment of Medical Oncology, Adana City Training and Research Hospital, University of Health Sciences, Adana, Turkey.ORCID http://orcid.org/0000-0002-5033-1479
Berna Bozkurt DumanDepartment of Medical Oncology, Adana City Training and Research Hospital, University of Health Sciences, Adana, Turkey.ORCID http://orcid.org/0000-0003-0295-6295
Sağlık Bilimleri Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe study aims to investigate the estrogen-agonistic effects of tamoxifen on voice parameters in premenopausal women diagnosed with breast cancer.

methodsA total of 108 premenopausal women were included, segmented into distinct treatment groups and a control group. Objective sound analysis was conducted using robust statistical methods, employing SPSS 25.0 for data analysis.

resultsThe study identified a statistically significant reduction in Jitter values across all treatment groups compared to the control group. No significant changes were observed in other voice quality parameters such as F0, Shimmer, NHR, and HNR.

conclusionsThe findings suggest that tamoxifen may have an estrogen-agonistic effect on voice quality, thereby potentially influencing future treatment protocols. This research fills a critical void in existing literature and sets the stage for more comprehensive studies that consider affects of hormonal therapies to voice.

Indexed as

Breast NeoplasmsVoiceAcousticsEstrogensFemaleHumansSpeech AcousticsTamoxifenVoice QualityEstrogensTamoxifenAcousticsBreast cancerEstrogenObjective sound analysisPremenopausal womenTamoxifenVoice analysis

Identifiers

PMID37947817
OpenAlexW4388571434

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.